Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Literature
1.
Aslani P, Benrimoj S, Krass I. Use of CMI by NSW community pharmacists—a baseline study. Aust Pharm. 1998;17:15–20.
2.
Koo M, Krass I, Aslani P. Patient characteristics influencing evaluation of written medicine information: lessons for patient education. Ann Pharmacother. 2005;39:1434–40.CrossRefPubMed
3.
Koo M, Krass I, Aslani P. Consumer use of consumer medicine information. J Pharm Pract Res. 2005;35(2):94–8.
4.
Koo M, Krass I, Aslani P. Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information. Health Expect. 2006;9:174–87.CrossRefPubMed
5.
Raynor D, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2000;264:268–70.
Metadata
Title
Written medicine information in Australia
Author
Parisa Aslani
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9329-5

Other articles of this Issue 6/2009

International Journal of Clinical Pharmacy 6/2009 Go to the issue

Short Research Report

Electronic reminders to improve medication adherence—are they acceptable to the patient?

Case Report

Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine

Research Article

Clinical pharmacy services in an Iranian teaching hospital: a descriptive study

Research Article

Adolescents in Spain: use of medicines and adolescent lifestyles

Research Article

Care of the stroke patient—communication between the community pharmacist and prescribers in the Republic of Ireland

Research Article

Pharmacy students’ attitudes toward pharmaceutical care in Riyadh region Saudi Arabia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits